Melatonin Holds Promise for ALS

In Mice Melatonin Delays ALS Symptom Onset And Death

In Medical News Today is an article on using melatonin for the treatment of ALS (Lou Gehrig’s disease).  What the research team found was melatonin was a powerful antioxidant that helps to block and slow down enzymes that cause cell death.

The experiments found that a lack of melatonin and their receptors were connected with the progression of ALS.

The mice that were treated with melatonin lived longer and developed the symptoms slower than the non-treated mice.

This research holds great promise in the treatment of ALS.

Source: http://www.medicalnewstoday.com/releases/259647.php

Sharing This

About John Montague DC

John Montague DC is the owner of WebVitamins. He is active in the industry and is currently president of the NPA East.

Speak Your Mind

*

Sharing This

facebooktwittergoogle_pluspinterestmailby feather